Global Health

US FDA authorizes Novavax's updated COVID shot, shares rise The U.S. Food and Drug Administration said on Tuesday it authorized an updated version of Novavax's COVID-19 vaccine for emergency use in individuals aged 12 years and older, and the company's shares closed 8% higher. Sriparna Roy,Michael Erman Reuters

...

Moderna combination Covid, flu vaccine shows positive data (cnbc.com)

• Moderna on Wednesday said its combination vaccine targeting Covid and the flu will move to a final stage trial after showing positive results in an earlier study.
• The biotech company is hoping its shot, mRNA-1083, can win approval from regulators in 2025. 

...

FDA signs off on updated protein-based Covid-19 vaccine from Novavax | CNN The US Food and Drug Administration on Tuesday authorized Novavax’s updated protein-based Covid-19 vaccine for people 12 and older. Amanda Sealy, Brenda Goodman CNN

This vaccine is effective against EG.5, the currently dominant coronavirus strain in the United States, and like Pfizer and Moderna’s mRNA vaccines, it has been updated to target the XBB Omicron subvariant.

Study: Paxlovid cuts hospitalization, death only in at-risk COVID patients with weak immune systems seb_ra / iStock CIDRAP

...in JAMA Network Open, an observational Canadian study ties the antiviral drug combo nirmatrelvir-ritonavir (Paxlovid) to a lower risk of hospitalization or death only in very high-risk COVID-19 patients with weakened immune systems.

...